-
161
Randomized controlled trial combining constraint-induced movement therapy and action-observation training in unilateral cerebral palsy: clinical effects and influencing factors of...
Published 2020-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
162
Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience
Published 2017-12-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
163
Sleep outcomes and related factors in Parkinson’s disease after subthalamic deep brain electrode implantation: a retrospective cohort study
Published 2023-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
164
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China
Published 2024-04-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
165
Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis
Published 2019-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
166
Corrigendum to “Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance”
Published 2021-10-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
167
Mechanical thrombectomy in a young stroke patient with Duchenne muscular dystrophy
Published 2018-02-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
168
Embolic strokes of undetermined source: theoretical construct or useful clinical tool?
Published 2019-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
169
Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study
Published 2023-02-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
170
Efficacy and safety of laquinimod in multiple sclerosis: current status
Published 2013-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
171
Flow diversion for posterior circulation aneurysms: a multicenter retrospective study
Published 2023-06-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
172
Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study
Published 2020-04-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
173
A review of the use of frovatriptan in the treatment of menstrually related migraine
Published 2013-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
174
Defining a role for laquinimod in multiple sclerosis
Published 2014-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
175
Cytotoxic corpus callosum lesion and mild CSF pleocytosis during hantavirus infection: a case report
Published 2022-12-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
176
Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status
Published 2021-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
177
Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients
Published 2023-12-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
178
Improved visualization of median, ulnar nerves, and small branches in the wrist and palm using contrast-enhanced magnetic resonance neurography
Published 2024-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
179
The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience
Published 2017-02-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
180
The effects of treatment with pimavanserin on activities of daily living in patients with Parkinson’s disease psychosis: a 16-week, single-arm, open-label study
Published 2024-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article